|
Prelegenci
-
Prof. Jack Dowie
Emeritus Professor of Health Impact Analysis Public Health and Policy Dept London School of Hygiene and Tropical Medicine, UK
-
Prof. Michael Drummond
Professor of Health Economics Centre for Health Economics, University of York, UK
-
Prof. Bengt Jönsson
Professor of Health Economics, Stockholm School of Economics, Sweden
-
Prof. Gert van der Wilt
Department of Epidemiology, Biostatistics and HTA Radboud University Medical Centre Nijmegen, Nederlands
-
Chris Henshall
Pro Vice Chancellor for External Relations at the University of York, UK
-
Prof. David Banta
Professor Emeritus, University of Maastricht, Netherlands
-
Alexandre Lemgruber
Head of the Office of Economic Evaluation of New Technologies, at the Brazilian Health Agency - ANVISA, Brazil
-
Prof. Rod Taylor
Associate Professor in Health Services Research & Scientific Director of Peninsula Clinical Trials Unit, Peninsula Medical School, UK
-
Rabia Kahveci
President of Turkish Evidence Based Medicine Association, Turkey
-
J. Jaime Caro
President and Chief Executive Officer, Senior Vice President, UBC, USA
-
Joanna Mucha
Member of Parliament, academic lecturer, Poland
-
Wojciech Matusewicz
Director, AHTAPol, Poland
-
Prof. Zbigniew Szawarski
Institute of Philosophy, University of Warsaw, Poland
-
Prof. Jacek Ruszkowski
Director of the Public Health Center, Kozminski University, Poland
-
Jim Furniss
Director, Global Market Access Strategy Bridgehead International Limited, Leicestershire, UK
-
Prof. Paweł Vorobiev
President of Russia Society for Pharmacoeconomics Research, Russia
-
Zoltan Kalo
CEO at Syreon Research Institute, Director of Health Economics Research Centre at Eötvös Loránd University, Hungary
-
Dragana Atanasijevic
Local Consultant for HTA Project Coordination Unit Ministry of Health of Serbia, Serbia
-
Mitchell Sugarman
Sr. Director of Health Economics, Policy and Payment, Medtronic, USA
-
Jorge Wernli
VP Global Pricing & Government Affairs at Vifor Pharma, Switzerland
-
Anita Burrell
Head, Health Economics & Reimbursement PVD, Sanofi Aventis, France
-
Erin Huntington
Corporate Affairs Director Elli Lilly Europe, UK
-
Oleg Borisenko
Executive Director of Russia Society for Pharmacoeconomics Research, Russia
-
Joanna Lis
Manager of Health Economics Dept., Sanofi-Aventis Group, Poland
-
Krzysztof Łanda
CEO of HTA Audit, Poland
Precursor and promoter of EBM/HTA/EBHC in Poland. Author and co-author of numerous papers on methodology, guidelines and systemic studies. Initiator of education and training activities in the field of Health Technology Assessment, including the EBHC Symposium.
-
Magdalena Władysiuk
Vice-president of HTA Consulting, Poland
An expert in EBM, HTA and PhE; author of numerous training programs and research analyses in HTA.
-
Katarzyna Bondaryk
Hogan & Hartson, Poland
|
|